Dexrazoxane is a bisdioxopiperazine derivative utilized in oncology as a cardioprotective agent to mitigate anthracycline-induced cardiotoxicity by chelating metal ions and reducing oxidative damage. To… Read more

![Chemical structure of N-(2-Amino-2-oxoethyl)-N-[(1S)-2-(3,5-dioxo-1-piperazinyl)-1-methylethyl]-glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F120418-77-1-N-2-Amino-2-oxoethyl-N-1S-2-35-dioxo-1-piperazinyl-1-methylethyl-glycine.png&w=3840&q=75)


Dexrazoxane is a bisdioxopiperazine derivative utilized in oncology as a cardioprotective agent to mitigate anthracycline-induced cardiotoxicity by chelating metal ions and reducing oxidative damage. To support the rigorous quality control and regulatory compliance of this therapeutic, our catalogue provides a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality reference materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and stability testing. By providing structurally characterized analogs, including degradation products formed via hydrolysis or oxidation, these standards enable accurate identification and quantification of impurities in drug substances and formulations. Analytical chemists rely on these precise, documented compounds to ensure that dexrazoxane batches consistently meet safety and efficacy standards throughout the lifecycle of drug development and manufacturing.